Stay updated on RTXM83 Plus CHOP vs Rituximab Plus CHOP in NHL Clinical Trial
Sign up to get notified when there's something new on the RTXM83 Plus CHOP vs Rituximab Plus CHOP in NHL Clinical Trial page.

Latest updates to the RTXM83 Plus CHOP vs Rituximab Plus CHOP in NHL Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check16 days agoChange DetectedDifference0.3%
- Check23 days agoChange DetectedThe page has undergone significant content removal, particularly regarding a detailed study on the efficacy of RTXM83 for treating Diffuse Large B-cell Lymphoma, including its methodology, inclusion and exclusion criteria, and collaborator information. The revision number has also been updated from v2.14.4 to v2.15.0.SummaryDifference23%
- Check30 days agoChange DetectedThe web page has been updated to version 2.14.4, replacing the previous version 2.14.3.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.1%
- Check45 days agoChange DetectedDifference0.2%
Stay in the know with updates to RTXM83 Plus CHOP vs Rituximab Plus CHOP in NHL Clinical Trial
Enter your email address, and we'll notify you when there's something new on the RTXM83 Plus CHOP vs Rituximab Plus CHOP in NHL Clinical Trial page.